P. Sfikakis

436 total citations
23 papers, 356 citations indexed

About

P. Sfikakis is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, P. Sfikakis has authored 23 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in P. Sfikakis's work include Systemic Lupus Erythematosus Research (7 papers), Immunotherapy and Immune Responses (4 papers) and Ocular Diseases and Behçet’s Syndrome (4 papers). P. Sfikakis is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Immunotherapy and Immune Responses (4 papers) and Ocular Diseases and Behçet’s Syndrome (4 papers). P. Sfikakis collaborates with scholars based in Greece, United States and United Kingdom. P. Sfikakis's co-authors include George C. Tsokos, Scott A. Vogelgesang, Kyriaki Aroni, Maria Tsokos, Bryan K. McCune, Stamatis Theocharis, Charles S. Via, P.P. Sfikakis, Birgit Kovacs and Robert N. Lipnick and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the Neurological Sciences and Calcified Tissue International.

In The Last Decade

P. Sfikakis

21 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sfikakis Greece 13 133 127 63 62 33 23 356
Takeshi Kezuka Japan 14 111 0.8× 124 1.0× 153 2.4× 65 1.0× 11 0.3× 20 495
Giordani Rodrigues dos Passos Brazil 9 79 0.6× 85 0.7× 262 4.2× 56 0.9× 5 0.2× 17 377
Sofia Töyrä Silfverswärd Sweden 11 128 1.0× 84 0.7× 28 0.4× 105 1.7× 4 0.1× 25 341
Jitesh Rana United States 4 123 0.9× 59 0.5× 247 3.9× 55 0.9× 10 0.3× 10 382
Haritz Irizar Spain 12 108 0.8× 34 0.3× 141 2.2× 243 3.9× 17 0.5× 21 500
Alberto Hidalgo Tuñón Spain 7 94 0.7× 47 0.4× 60 1.0× 76 1.2× 4 0.1× 28 264
Steffen Pfeuffer Germany 15 176 1.3× 79 0.6× 360 5.7× 89 1.4× 6 0.2× 53 588
Wladimir Mauhin France 9 49 0.4× 61 0.5× 29 0.5× 118 1.9× 23 0.7× 22 356
Martina Kunkl Italy 11 183 1.4× 24 0.2× 95 1.5× 110 1.8× 4 0.1× 16 406
David D. Hebrink United States 13 264 2.0× 103 0.8× 207 3.3× 144 2.3× 3 0.1× 16 495

Countries citing papers authored by P. Sfikakis

Since Specialization
Citations

This map shows the geographic impact of P. Sfikakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sfikakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sfikakis more than expected).

Fields of papers citing papers by P. Sfikakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sfikakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sfikakis. The network helps show where P. Sfikakis may publish in the future.

Co-authorship network of co-authors of P. Sfikakis

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sfikakis. A scholar is included among the top collaborators of P. Sfikakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sfikakis. P. Sfikakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kalra, Seema, Alan J. Silman, G. Akman‐Demir, et al.. (2013). Diagnosis and management of neuro-Behçet's disease: International consensus recommendations. Journal of the Neurological Sciences. 333. e720–e720. 6 indexed citations
3.
Arida, Aikaterini, Georgios Vaiopoulos, Nikos N. Markomichelakis, P. Kaklamanis, & P. Sfikakis. (2010). Are clusters of patients with distinct clinical expression present in Behçet's disease?. PubMed. 27(2 Suppl 53). S48–51. 12 indexed citations
4.
Poulopoulou, Cornelia, Z. Papadopoulou‐Daifoti, Alexandros Hatzimanolis, et al.. (2008). Glutamate levels and activity of the T cell voltage‐gated potassium Kv1.3 channel in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 58(5). 1445–1450. 19 indexed citations
5.
Katsiari, Christina, et al.. (2006). Successful Long-term Treatment of Refractory Adamantiades-Behçet’ss Disease (ABD) with Infliximab: Report of Two Patients. Kluwer Academic Publishers eBooks. 528. 551–555. 10 indexed citations
6.
Elezoglou, Antonia, P. Sfikakis, George Vaiopoulos, Violeta Kapsimali, & Phaedon Kaklamanis. (2006). Serum Levels of Soluble TNF-α Receptor-II (P75), Circulating γδ T-Cells and Adamantiades-behçet’s Disease Activity. Kluwer Academic Publishers eBooks. 261–265. 6 indexed citations
7.
Sfikakis, P., et al.. (1998). Short Communication Tamoxifen exerts testosterone-dependent and independent effects on thymic involution. International Journal of Immunopharmacology. 20(6). 305–312. 17 indexed citations
8.
Sfikakis, P., et al.. (1998). Effects of 2-Chlorodeoxyadenosine and Gold Sodium Thiomalate on Human bcl-2 Gene Expression. Immunopharmacology and Immunotoxicology. 20(1). 63–77. 2 indexed citations
9.
Vogelgesang, Scott A., Melvyn P. Heyes, Sterling G. West, et al.. (1996). Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations.. PubMed. 23(5). 850–5. 32 indexed citations
10.
Tsokos, George C., Birgit Kovacs, P. Sfikakis, et al.. (1996). Defective antigen‐presenting cell function in patients with systemic lupus erythematosus: Role of the B7‐1 (CD80) costimulatory molecule. Arthritis & Rheumatism. 39(4). 600–609. 45 indexed citations
11.
12.
Sfikakis, P., Vassilis L. Souliotis, Ν. Katsilambros, et al.. (1996). Downregulation of Interleukin-2 and α-Chain Interleukin-2 Receptor Biosynthesis by Cisplatin in Human Peripheral Lymphocytes. Clinical Immunology and Immunopathology. 79(1). 43–49. 17 indexed citations
13.
Sfikakis, P., et al.. (1995). Cd28 expression on t cell subsets in vivo and cd28‐mediated t cell response in vitro in patients with rheumatoid arthritis. Arthritis & Rheumatism. 38(5). 649–654. 25 indexed citations
14.
Sfikakis, P., et al.. (1994). Reply. Arthritis & Rheumatism. 37(1). 147–147. 1 indexed citations
15.
Sfikakis, P., Robert J. Oglesby, P.P. Sfikakis, & George C. Tsokos. (1994). B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clinical & Experimental Immunology. 96(1). 8–14. 20 indexed citations
16.
Sfikakis, P., et al.. (1993). Immunohistological Demonstration of Transforming Growth Factor-β Isoforms in the Skin of Patients with Systemic Sclerosis. Clinical Immunology and Immunopathology. 69(2). 199–204. 56 indexed citations
17.
18.
Lipnick, Robert N., P. Sfikakis, Gary L. Klipple, & George C. Tsokos. (1993). Elevated Soluble CD8 Antigen and Soluble Interleukin-2 Receptors in the Sera of Patients with Juvenile Rheumatoid Arthritis. Clinical Immunology and Immunopathology. 68(1). 64–67. 13 indexed citations
19.
Karameris, Andreas, Vassilis G. Gorgoulis, Alexios Iliopoulos, et al.. (1992). Detection of the Epstein Barr viral genome by an in situ hybridization method in salivary gland biopsies from patients with secondary Sjögren's syndrome.. PubMed. 10(4). 327–32. 16 indexed citations
20.
Mavrikakis, Myron, et al.. (1991). Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritis. Calcified Tissue International. 49(4). 288–291. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Kezuka Breakdown of academic impact, for papers by Giordani Rodrigues dos Passos Breakdown of academic impact, for papers by Sofia Töyrä Silfverswärd Breakdown of academic impact, for papers by Jitesh Rana Breakdown of academic impact, for papers by Haritz Irizar Breakdown of academic impact, for papers by Alberto Hidalgo Tuñón Breakdown of academic impact, for papers by Steffen Pfeuffer Breakdown of academic impact, for papers by Wladimir Mauhin Breakdown of academic impact, for papers by Martina Kunkl Breakdown of academic impact, for papers by David D. Hebrink
Rankless by CCL
2026